Cite
HARVARD Citation
Abushakra, S. et al. (n.d.). Effects of Oral ALZ‐801, an Amyloid Oligomer Inhibitor, on Plasma Biomarkers in APOE4 Carriers with Early Alzheimer's Disease: Results of Six‐month Interim Analysis from a Phase 2 Biomarker Study. Alzheimer's & dementia. p. n/a. [Online].